Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a report published on Tuesday. The firm issued a hold rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Trading Up 6.6 %

MLSS opened at $1.30 on Tuesday. Milestone Scientific has a 12-month low of $0.54 and a 12-month high of $1.32. The company has a market cap of $101.26 million, a price-to-earnings ratio of -18.57 and a beta of 1.10. The stock has a fifty day simple moving average of $0.93 and a two-hundred day simple moving average of $0.92.

Hedge Funds Weigh In On Milestone Scientific

Several large investors have recently modified their holdings of MLSS. Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific in the 3rd quarter worth $48,000. World Investment Advisors LLC purchased a new stake in Milestone Scientific in the 3rd quarter worth approximately $91,000. Carnegie Investment Counsel raised its position in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares during the period. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.